Total Payments
$9,622
2024 Payments
$1,141
Companies
31
Transactions
356
Medicare Patients
4,608
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$9,349 (97.2%)
Education$272.81 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,349 | 343 | 97.2% |
| Education | $272.81 | 13 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,272 | 44 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $1,206 | 48 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $757.55 | 26 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $735.27 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $650.07 | 31 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $640.00 | 23 | $0 (2022) |
| Keryx Biopharmaceuticals, Inc. | $601.41 | 15 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $497.18 | 9 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $413.32 | 15 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $384.94 | 17 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,141 | 47 | Fresenius USA Marketing, Inc. ($170.93) |
| 2023 | $1,346 | 48 | Mallinckrodt Hospital Products Inc. ($352.19) |
| 2022 | $1,053 | 43 | Vifor Pharma, Inc. ($192.55) |
| 2021 | $807.22 | 24 | AKEBIA THERAPEUTICS INC ($227.51) |
| 2020 | $443.18 | 26 | AstraZeneca Pharmaceuticals LP ($90.53) |
| 2019 | $1,582 | 61 | OPKO Pharmaceuticals, LLC ($406.63) |
| 2018 | $1,769 | 56 | Keryx Biopharmaceuticals, Inc. ($396.67) |
| 2017 | $1,480 | 51 | Amgen Inc. ($257.13) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.50 | General |
| 11/13/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Nephrology | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: NEPHROLOGY | ||||||
| 10/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.27 | General |
| 10/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Hyperkalemia | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Nephrology | ||||||
| 09/18/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardio-renal | ||||||
| 08/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Hyperkalemia | ||||||
| 07/31/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEPHROLOGY | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: Rare Disease | ||||||
| 06/05/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Hyperkalemia | ||||||
| 05/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,138 | 2,529 | $656,175 | $259,851 |
| 2022 | 11 | 1,279 | 2,882 | $741,850 | $303,359 |
| 2021 | 11 | 1,197 | 2,692 | $728,075 | $316,324 |
| 2020 | 11 | 994 | 2,360 | $652,550 | $264,407 |
Total Patients
4,608
Total Services
10,463
Medicare Billing
$1.1M
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 421 | 1,045 | $191,500 | $75,501 | 39.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 290 | 329 | $82,250 | $39,345 | 47.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 28 | 150 | $90,000 | $38,349 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 339 | $67,800 | $36,511 | 53.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 141 | 436 | $130,800 | $28,167 | 21.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 23 | 65 | $39,000 | $19,743 | 50.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 96 | $19,725 | $10,428 | 52.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 15 | 48 | $28,800 | $8,483 | 29.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $6,300 | $3,323 | 52.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 439 | 1,124 | $196,700 | $74,407 | 37.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 33 | 181 | $108,600 | $49,674 | 45.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 281 | 323 | $80,750 | $40,907 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 324 | $64,800 | $36,554 | 56.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 143 | 495 | $148,500 | $33,186 | 22.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 22 | 69 | $41,400 | $22,450 | 54.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 203 | $40,600 | $19,269 | 47.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 69 | $20,700 | $12,753 | 61.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 20 | 52 | $31,200 | $9,762 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $5,750 | $3,577 | 62.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 16 | 19 | $2,850 | $818.98 | 28.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 408 | 1,108 | $192,500 | $74,584 | 38.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 55 | 201 | $120,600 | $56,163 | 46.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 34 | 154 | $92,400 | $52,256 | 56.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 228 | 263 | $65,750 | $33,702 | 51.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 280 | $55,200 | $33,097 | 60.0% |
About Dr. Christopher Caputo, M.D
Dr. Christopher Caputo, M.D is a Nephrology healthcare provider based in Mineola, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992703490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Caputo, M.D has received a total of $9,622 in payments from pharmaceutical and medical device companies, with $1,141 received in 2024. These payments were reported across 356 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,349).
As a Medicare-enrolled provider, Caputo has provided services to 4,608 Medicare beneficiaries, totaling 10,463 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Mineola, NY
- Active Since 07/08/2005
- Last Updated 11/03/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1992703490
Products in Payments
- Velphoro (Drug) $1,109
- Auryxia (Drug) $915.38
- ACTHAR (Biological) $882.12
- Rayaldee (Drug) $615.13
- Parsabiv (Biological) $572.31
- JYNARQUE (Drug) $483.50
- Veltassa (Drug) $407.06
- Aranesp (Biological) $336.67
- AURYXIA (Drug) $326.03
- KRYSTEXXA (Biological) $317.01
- CardioMEMS HF System (Device) $315.36
- Kerendia (Drug) $269.06
- FARXIGA (Drug) $267.09
- SAMSCA (Drug) $251.77
- ULTOMIRIS (Biological) $244.49
- LOKELMA (Drug) $224.99
- TAVNEOS (Drug) $169.95
- TARPEYO (Drug) $138.60
- SOLIRIS (Drug) $137.70
- BENLYSTA (Biological) $127.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Mineola
Eduard Bover, D.o, D.O
Nephrology — Payments: $7,922
Nephrology $7,922
Dr. Vincent Avila, M.d, M.D
Nephrology — Payments: $4,087
Nephrology $4,087
Dr. Yelena Rosenberg, M.d, M.D
Nephrology — Payments: $3,838
Nephrology $3,838
Dr. Madhusudana Korrapati, M.d, M.D
Nephrology — Payments: $1,497
Nephrology $1,497
John Maesaka, M.d, M.D
Nephrology — Payments: $939.54
Nephrology $939.54
Dr. Mario Marotta, M.d, M.D
Nephrology — Payments: $584.55
Nephrology $584.55